1. Zhao C, Habtewold TD, Naderi E, Liemburg EJ, Bruggeman R, Alizadeh BZ, GROUP Investigators. Association of clinical symptoms and cardiometabolic dysregulations in patients with schizophrenia spectrum disorders. Eur Psychiatry. 2023;67(1):e7.
2. Habtewold TD, Islam MA, Liemburg EJ, GROUP Investigators, Bruggeman R, Alizadeh BZ. Polygenic risk score for schizophrenia was not associated with glycemic level (HbA1c) in patients with non-affective psychosis: Genetic Risk and Outcome of Psychosis (GROUP) cohort study. J Psychosom Res. 2020 132:109968.
3. Habtewold TD, Bruggeman R, Liemburg EJ, Islam MA, Alizadeh BZ. The effect of (poly)genetic risk score of schizophrenia and type 2 diabetes and antipsychotic medication use on glycemic dysregulation. Eur Neuropsychopharmacol. 2019;29(S4):1335. [Abstract]
4. Habtewold TD, Islam MA, Liemburg EJ, Bruggeman R, Alizadeh BZ. Effect of genetic susceptibility to schizophrenia and type 2 diabetes mellitus on hyperglycemia in patients with schizophrenia. Genet. Epidemiol. 2018;42(7):684-748. [Abstract]
5. Mohammed SH, Habtewold TD, Birhanu MM, Sissay TA, Tegegne BS, Abuzerr S, Esmaillzadeh A. Neighbourhood socioeconomic status and overweight/obesity: a systematic review and meta-analysis of epidemiological studies. BMJ Open. 2019;9(11):e028238.
6. Habtewold TD, Tsega WD, Wale BY. Diabetes mellitus in outpatients in Debre Berhan referral hospital, Ethiopia. J Diabetes Res. 2016;2016:3571368.
7. GBD 2019 Diabetes Mortality Collaborators. Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019. Lancet Diabetes Endocrinol. 2022;10(3):177-92.
8. GBD 2019 Diabetes and Air Pollution Collaborators. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019. Lancet Planet Health. 2022;6(7):e586-e600.
9. Dessie G, Wagnew F, Mulugeta H, Belachew A, Negesse A, Kassa GM, Habtewold TD, Parchinski K. Association Between the Level of Reported Good Medication Adherence and the Geographic Location of a Patient’s Residence and Presence of a Glucometer Among Adult Diabetic Patients in Ethiopia: A Systematic Review and Meta-analysis. Curr Ther Res Clin Exp. 2020;92:100585. eCollection 2020.
10. Tegegne BS, Mengesha MM, Teferra AA, Awoke MA, Habtewold TD. Association between diabetes mellitus and multi-drug-resistant tuberculosis: evidence from a systematic review and meta-analysis. Syst Rev. 2018;7(1):161.
11. GBD 2015 Eastern Mediterranean Region Obesity Collaborators. Burden of obesity in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study. Int J Public Health. 2018;63(Suppl 1):165-176.
12. GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1345-422.
13. GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13-27.
14. GBD 2015 Cardiovascular Disease Collaborators. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017;70(1):1-25.
15. Mohammed SH, Birhanu MM, Sissay TA, Habtewold TD, Tegegn BS, Esmaillzadeh A. What does my neighbourhood have to do with my weight?A protocol for systematic review and meta analysis of the association between neighbourhood socioeconomic status and body weight. BMJ open. 2017;7(9):e017567.
16. Tegegne BS, Habtewold TD, Mengesha MM, Burgerhof JG. Association between diabetes mellitus and multi-drug-resistant tuberculosis: a protocol for a systematic review and meta-analysis. Syst Rev. 2017;6(1):6.